| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Active management of mild obstructive sleep apnoea: the evidence grows
|
McNicholas, Walter T
|
|
|
8 |
4 |
p. 322-323
|
artikel
|
| 2 |
Adoption of COVID-19 triage strategies for low-income settings
|
Ayebare, Rodgers R
|
|
|
8 |
4 |
p. e22
|
artikel
|
| 3 |
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
|
Fang, Lei
|
|
|
8 |
4 |
p. e21
|
artikel
|
| 4 |
Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study
|
Turner, Carolin T
|
|
|
8 |
4 |
p. 407-419
|
artikel
|
| 5 |
Blood transcriptional signatures for tuberculosis testing
|
Mendelsohn, Simon C
|
|
|
8 |
4 |
p. 330-331
|
artikel
|
| 6 |
Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis
|
Gupta, Rishi K
|
|
|
8 |
4 |
p. 395-406
|
artikel
|
| 7 |
Continuous positive airway pressure versus standard care for the treatment of people with mild obstructive sleep apnoea (MERGE): a multicentre, randomised controlled trial
|
Wimms, Alison J
|
|
|
8 |
4 |
p. 349-358
|
artikel
|
| 8 |
Correction to Lancet Respir Med 2020; 8: 420–22
|
|
|
|
8 |
4 |
p. e26
|
artikel
|
| 9 |
Correction to Lancet Respir Med 2020; 8: e20
|
|
|
|
8 |
4 |
p. e26
|
artikel
|
| 10 |
Correction to Lancet Respir Med 2020; published online Feb 21. https://doi.org/10.1016/S2213-2600(20)30079-5
|
|
|
|
8 |
4 |
p. e26
|
artikel
|
| 11 |
COVID-19: delay, mitigate, and communicate
|
The Lancet Respiratory Medicine,
|
|
|
8 |
4 |
p. 321
|
artikel
|
| 12 |
COVID-19, ECMO, and lymphopenia: a word of caution
|
Henry, Brandon Michael
|
|
|
8 |
4 |
p. e24
|
artikel
|
| 13 |
COVID-19: the need for continuous medical education and training
|
Li, Li
|
|
|
8 |
4 |
p. e23
|
artikel
|
| 14 |
Cystic fibrosis in Turkey
|
Dogru, Deniz
|
|
|
8 |
4 |
p. e17
|
artikel
|
| 15 |
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis
|
Lan, Zhiyi
|
|
|
8 |
4 |
p. 383-394
|
artikel
|
| 16 |
Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial
|
Sánchez-de-la-Torre, Manuel
|
|
|
8 |
4 |
p. 359-367
|
artikel
|
| 17 |
Evolving therapies for rifampicin-resistant tuberculosis: balancing efficacy and toxicity
|
Variava, Ebrahim
|
|
|
8 |
4 |
p. 326-328
|
artikel
|
| 18 |
Gag clause prevents discussion of assisted dying in Victoria, Australia
|
Kirby, Tony
|
|
|
8 |
4 |
p. 341-342
|
artikel
|
| 19 |
Headway made towards biosignatures for incipient tuberculosis
|
Scriba, Thomas J
|
|
|
8 |
4 |
p. 328-330
|
artikel
|
| 20 |
Host-directed therapies and holistic care for tuberculosis
|
Zumla, Alimuddin
|
|
|
8 |
4 |
p. 337-340
|
artikel
|
| 21 |
Interstitial lung diseases: a call for papers
|
Grainger, Emma
|
|
|
8 |
4 |
p. 340
|
artikel
|
| 22 |
Obstructive sleep apnoea in acute coronary syndrome
|
Peker, Yüksel
|
|
|
8 |
4 |
p. e14
|
artikel
|
| 23 |
Obstructive sleep apnoea in acute coronary syndrome
|
Martinez-Garcia, Miguel A
|
|
|
8 |
4 |
p. e15
|
artikel
|
| 24 |
Obstructive sleep apnoea in acute coronary syndrome – Authors' reply
|
Sánchez-de-la-Torre, Manuel
|
|
|
8 |
4 |
p. e16
|
artikel
|
| 25 |
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
|
Xu, Zhe
|
|
|
8 |
4 |
p. 420-422
|
artikel
|
| 26 |
Patient support is vital to treatment adherence
|
Soe, Kyi Pyar
|
|
|
8 |
4 |
p. 346
|
artikel
|
| 27 |
Post-tuberculosis mortality and morbidity: valuing the hidden epidemic
|
Quaife, Matthew
|
|
|
8 |
4 |
p. 332-333
|
artikel
|
| 28 |
Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis
|
Chakaya, Jeremiah Muhwa
|
|
|
8 |
4 |
p. 334-335
|
artikel
|
| 29 |
Respiratory support for patients with COVID-19 infection
|
Ñamendys-Silva, Silvio A
|
|
|
8 |
4 |
p. e18
|
artikel
|
| 30 |
Sex difference and smoking predisposition in patients with COVID-19
|
Cai, Hua
|
|
|
8 |
4 |
p. e20
|
artikel
|
| 31 |
Speaking from the head and the heart
|
Morgan, Jules
|
|
|
8 |
4 |
p. 347-348
|
artikel
|
| 32 |
Staff safety during emergency airway management for COVID-19 in Hong Kong
|
Cheung, Jonathan Chun-Hei
|
|
|
8 |
4 |
p. e19
|
artikel
|
| 33 |
The role of policy in the EVALI outbreak: solution or contributor?
|
Smith, Danielle M
|
|
|
8 |
4 |
p. 343-344
|
artikel
|
| 34 |
Time to rename COPD exacerbations: implementing the term lung attack
|
Holverda, Sebastiaan
|
|
|
8 |
4 |
p. e25
|
artikel
|
| 35 |
Treatment for obstructive sleep apnoea and cardiovascular diseases: are we aiming at the wrong target?
|
Heinzer, Raphael
|
|
|
8 |
4 |
p. 323-325
|
artikel
|
| 36 |
Tuberculosis in children, adolescents, and women
|
Marais, Ben J
|
|
|
8 |
4 |
p. 335-337
|
artikel
|
| 37 |
Unmasked: we all breathe
|
Burki, Talha Khan
|
|
|
8 |
4 |
p. 348
|
artikel
|
| 38 |
Where next for inhaled corticosteroids in childhood asthma?
|
Sinha, Ian P
|
|
|
8 |
4 |
p. 345
|
artikel
|
| 39 |
Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study
|
Mishra, Hridesh
|
|
|
8 |
4 |
p. 368-382
|
artikel
|
| 40 |
Xpert MTB/RIF Ultra: what is the real impact?
|
Bonnet, Maryline
|
|
|
8 |
4 |
p. 325-326
|
artikel
|
Tijdschrift beschrijving